Le Lézard
Classified in: Health, Science and technology
Subject: EGV

Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptumtm for the Treatment of Schizophrenia

WASHINGTON, Nov. 10, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced today the refusal of the marketing authorization application (MAA) of Fanaptumtm (oral iloperidone tablets) for the treatment of schizophrenia in adult patients in the European Union.  In July 2017, the Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion, recommending the refusal of the Fanaptumtm MAA. Vanda requested a re-examination of the initial opinion. After considering the grounds for this request, the CHMP re-examined the opinion and confirmed the refusal of the Fanaptumtm MAA on November 9, 2017.

About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.  For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

About Fanapt®

For full U.S. Prescribing Information for Fanapt®, including indication, Boxed Warnings and Important Safety Information, visit our Web site at www.fanapt.com.

Investor Contact:
Jim Kelly
Executive Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428

SOURCE Vanda Pharmaceuticals Inc.

These press releases may also interest you

at 05:00
Leoni, a global provider of energy and data management solutions in the automotive sector and other industries, and the research and development company PARC, a Xerox company, providing cutting-edge innovation for nearly 50 years, today announced a...

at 05:00
Tru Optik, the leading audience intelligence and data-management platform across over-the-top (OTT) and connected TV (CTV) today announced the full release of its Cross-Screen Audience Validation (CAV) service which provides de-duplicated...

at 05:00
DNAmito, Inc. (Palo Alto, CA) a genomics-based precision oncology company, announced today that Mr. Dan Pelino has joined its board of directors. A globally recognized corporate leader, Dan led IBM's business in government, education, healthcare...

at 05:00
The Califin Global Crypto Exchange has officially launched the Beta version of its trading platform. Known as CGCX, the platform represents the world's first hybrid cryptocurrency investment solution. It hopes to attract a wide range of investors and...

at 05:00
Leading internet marketing company, fishbat, explains four ways plastic security seals companies can optimize their business YouTube channels to generate leads. To ensure that your channel is easily discovered and remains engaging for viewers, follow...

at 05:00
Information Services Group (ISG) , a leading global technology research and advisory firm, will be able to provide telecommunications spend recovery services to the UK Government under a new agreement with the Crown Commercial Service (CCS), an...

News published on 10 november 2017 at 16:05 and distributed by: